Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Shanghai and Shenzhen Markets: Three Major A-share Indices Rise 0.2% to 1.7% for the Day; YANGTZE OPTICAL FIBRE... (AAStocks) +++ YANGTZE OPTICAL Aktie -6,08%

MEDTRONIC Aktie

 >MEDTRONIC Aktienkurs 
64.5 EUR    +1.8%    (TradegateBSX)
Ask: 64.4 EUR / 86 Stück
Bid: 64.12 EUR / 86 Stück
Tagesumsatz: 2136 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
MEDTRONIC Aktie über LYNX handeln
>MEDTRONIC Performance
1 Woche: -5,3%
1 Monat: -8,3%
3 Monate: -24,9%
6 Monate: -28,3%
1 Jahr: -13,8%
laufendes Jahr: -23,1%
>MEDTRONIC Aktie
Name:  MEDTRONIC PLC DL-,0001
Land:  Irland
Sektor:  Gesundheit
ISIN/ Wkn:  IE00BTN1Y115 / A14M2J
Symbol/ Ticker:  2M6 (Frankfurt) / MDT (NYSE)
Kürzel:  FRA:2M6, ETR:2M6, 2M6:GR, NYSE:MDT
Index:  S&P500
Webseite:  https://www.medtronic.com..
Profil:  Medtronic plc is a global leader in medical technology, developing and manufacturing devices and therapies that address over 70 health conditions. The company operates across four main portfolios: Cardiovascular, which includes cardiac ablation solut..
>Volltext..
Marktkapitalisierung:  81681.6 Mio. EUR
Unternehmenswert:  98480.77 Mio. EUR
Umsatz:  30514.35 Mio. EUR
EBITDA:  8212.72 Mio. EUR
Nettogewinn:  3969.63 Mio. EUR
Gewinn je Aktie:  3.09 EUR
Schulden:  24140.24 Mio. EUR
Liquide Mittel:  986.39 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  0.88
Umsatzwachstum:  -6.57%
Gewinnwachstum:  -5.26%
Dividende je Aktie:  2.44 EUR
Dividendenrendite:  3.84%
Dividendenschätzung:  3.8%
Div. Historie:  27.03.26 - 0.616848€
29.12.25 - 0.60421€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  MEDTRONIC
Letzte Datenerhebung:  03.06.26
>MEDTRONIC Kennzahlen
Aktien/ Unternehmen:
Aktien: 1283.89 Mio. St.
Frei handelbar: 99.9%
Rückkaufquote: 0.37%
Mitarbeiter: 95000
Umsatz/Mitarb.: 0.3 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 42.33%
Bewertung:
KGV: 20.85
KGV lG: 13.4
KUV: 2.69
KBV: 1.96
PEG-Ratio: 2.33
EV/EBITDA: 11.99
Rentabilität:
Bruttomarge: 59.59%
Gewinnmarge: 13.01%
Operative Marge: 18.23%
Managementeffizenz:
Gesamtkaprendite: 5.09%
Eigenkaprendite: 9.38%
 >MEDTRONIC Anleihen 
>MEDTRONIC Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Nierenerkrankungen & -behandlung, Stoffwechselerkrankungen (Diabetes/ Adipositas), Herz-Kreislauf- Behandlung/ Kardiologie
 
03.06.26 - 04:36
Ihre wichtigsten Termine: Alle Blicke auf: Broadcom, Macy′s, Lyft, Medtronic, Palantir und Gerresheimer! (Wallstreet-Online)
 
Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag....
02.06.26 - 19:03
Medtronic Q4 preview: What to expect (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.06.26 - 13:12
Is Medtronic Stock Underperforming the Nasdaq? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
29.05.26 - 17:00
Seeking Clues to Medtronic (MDT) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
 
Get a deeper insight into the potential performance of Medtronic (MDT) for the quarter ended April 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics....
27.05.26 - 17:30
Analysts Estimate Medtronic (MDT) to Report a Decline in Earnings: What to Look Out for (Zacks)
 
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
27.05.26 - 17:01
Medtronic-Aktie: Optionsmarkt impliziert 4,1 % Kursbewegung zur Zahlenvorlage (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
27.05.26 - 01:00
Medtronic (MDT) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
 
In the closing of the recent trading day, Medtronic (MDT) stood at $77.6, denoting a -1.27% move from the preceding trading day....
26.05.26 - 22:45
ISRG vs. MDT: Which Surgical Robot Stock Is the Better Buy? (Zacks)
 
ISRG is widening its robotic surgery lead with faster growth, rising procedures and a recurring revenue model as Medtronic builds Hugo....
26.05.26 - 19:00
Broad-Based MedSurg Growth Likely to Aid MDT′s Q4 Performance (Zacks)
 
Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes....
22.05.26 - 21:18
Weekly Buzz: Guardant Health Wins FDA Nod; NMPA Green Lights HUTCHMED; Medtronic To Acquire SPR Therapeutics; Biogen Halts BIIB112 (AFX)
 
WESTON (dpa-AFX) - This week's biotech landscape saw regulatory approvals across the U.S., Canada, and China, alongside collaborations, acquisitions, program halts, and positive data readouts span......
22.05.26 - 19:45
Can MDT Stock Gain From Its Planned Acquisition of SPR Therapeutics? (Zacks)
 
Medtronic eyes a $650 million acquisition of SPR, adding the FDA-cleared SPRINT PNS System to expand its chronic pain treatment offerings ahead of the fiscal 2027 closing....
20.05.26 - 17:15
Medtronic to acquire pain therapy developer SPR for $650M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.05.26 - 16:48
Medtronic kauft Schmerzspezialisten SPR Therapeutics für 650 Millionen US-Dollar (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
20.05.26 - 15:48
Medtronic To Acquire SPR Therapeutics (AFX)
 
WASHINGTON (dpa-AFX) - Medtronic plc (MDT) announced intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company. The transaction consists of an upfront cash paymen......
20.05.26 - 15:18
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain (PR Newswire)
 
Acquisition will enhance Medtronic's Neuromodulation portfolio with temporary peripheral nerve stimulation (PNS) technology, enabling earlier intervention for chronic pain sufferers GALWAY, Ireland, May 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global healthcare technology......
19.05.26 - 01:00
Medtronic (MDT) Advances While Market Declines: Some Information for Investors (Zacks)
 
The latest trading day saw Medtronic (MDT) settling at $77.32, representing a +1.54% change from its previous close....
18.05.26 - 20:24
Bull & Bear: CSX, DAX, Medtronic, Ryanair, Zscaler - ICF BANK Video (4investors)
 
Um den gesamten Artikel unter 4investors.de zu lesen, klicken Sie bitte auf die Überschrift...
18.05.26 - 20:09
Medtronic dividend preview: 47-year growth streak set to continue (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.05.26 - 19:06
Mental Health Matters at Medtronic. Explore Our Employee Benefits (Accesswire)
 
At Medtronic, supporting mental health means offering employees practical tools they can use in real life NORTHAMPTON, MA / ACCESS Newswire / May 18, 2026 / At Medtronic, supporting mental health m......
18.05.26 - 08:03
Tulyp Medical Appoints Industry Veteran Steve Motes as CEO to Lead Next Phase of Growth in the US (Business Wire)
 
Steve Motes brings deep expertise in Mechanical Circulatory Support (MCS) and early-stage company leadership Company backed by Sofinnova Partners and leading medtech entrepreneurs and cardiologists PARIS & DALLAS--(BUSINESS WIRE)--Tulyp Medical, a Paris-based medical device company developing an intelligent pressure-driven perfusion system, today announced the appointment of Steve Motes as Chief Executive Officer. The appointment follows positive results from the company's first-in-human study. Steve joins Tulyp with more than 30 years of experience in the medical device industry, primarily focused on cardiovascular technologies. He has held leadership roles at Draeger, Medtronic (formerly Somanetics), Edwards Lifesciences, and Abbott. At Abbott, he contributed to the launch of the HeartMate 3 LVAD system and played a key role in expanding the company's ECMO business. More recently, he has served as CEO of several early-stage companies, including those in the MCS space. “I am thrilled to join Tulyp at...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Tor läßt all seinem Zorn den Lauf. - Altes Testament: Spruch
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!